Monocyte deactivation in septic patients: Restoration by IFN-γ treatment

Nature Medicine

Volumn 3, Issue 6, 1997, Pages 678-681

  Döcke, Wolf Dietrich ^a   Randow, Felix ^a   Syrbe, Uta ^a   Krausch, Dietmar ^a   Asadullah, Khusru ^a   Reinke, Petra ^a   Volk, Hans Dieter ^a   Kox, Wolfgang ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; LEUKOCYTE FUNCTION; MONOCYTE; MORTALITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, DRUG; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MIDDLE AGED; MONOCYTES; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030917203     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0697-678     Document Type: Article

References (20)

1. Volk, H. D. et al. Diagnostic value of an immune monitoring program for the clinical management of immunosuppressed patients with septic complications. Clin. Transplant. 3, 246-252 (1989).
2. Volk, H.D. et al. Alterations in function and phenotype of monocytes from patients with septic disease: Predictive value and new therapeutic strategies. in Host Defense Dysfunction in Trauma, Shock and Sepsis, (eds. Faist, E. and Meakins, J.L.) 246-271 (Springer-Verlag, Berlin-Heidelberg-New York, 1993).
3. Döcke, W. D. et al. Monocytic deactivation in fatal septic disease - Role of tumor necrosis factor-α and interleukin-10. in The Immune Consequences of Trauma, Shock and Sepsis - Mechanisms and Therapeutic Approaches. Vol. 1, MOF, MODS and SIRS: Basic Mechanisms in Inflammation and Tissue Injury, (eds. Faist, E., Baue, A.E. & Schildberg, F.W.) 162-168 (Pabst Science Publishers, Lengerich, Germany, 1996).
4. Randow, F. Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor beta. J. Exp. Med. 181, 1887-1892 (1995).
5. Beutler, B., Milsark, I.W. & Cerami, A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869-871 (1985).
6. Natanson, C., Hoffman, W.D., Suffredini, A.F., Eichacker, P.Q. & Danner, R.L. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120, 771-783 (1994).
7. Fisher, C.J. et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebo-controlled trial. JAMA 271, 1836-1843 (1994).
8. Fisher, C.J. et al. Treatment of septic shock with the tumor necrosis factor recepton:Fc fusion protein. N. Engl. J. Med. 334, 1697-1702 (1996).
9. Echtenacher, B., Falk, W., Mannel, D.N. & Krammer, P.H. Requirement of endoge-nous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145, 3762-3766 (1990).
10. Pfeffer, K. et al. Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457-467 (1993).
11. Platzer, C., Meisel, C., Vogt, K., Platzer, M. & Volk, H.D. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int. Immunol. 7, 517-523 (1995).
12. Bone, R.C. Sir Isaac Newton, sepsis, and CARS. Crit. Core Med. 24, 1125-1128 (1996).
13. Munoz, C. et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88, 1747-1754 (1991).
14. Faist, E. et al. Immunomodulatory therapy with thymopentin and indomethacin: Successful restoration of interleukin-2 synthesis in patients undergoing major surgery. Ann. Surg. 214, 264-273 (1991).
15. Young, H.A. & Hardy, K.J. Role of interferon-gamma in immune cell regulation. J. Leukocyt. Biol. 58, 373-381 (1995).
16. 2 of TNF-alpha and IL-1 production by human monocytes. Immunology 66, 376-383 (1989).
17. Donnelly, R.P., Freeman, S.L. & Hayes, M.P. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. J. Immunol. 155, 1420-1427 (1995).
18. Heinzel, F.P. The role of IFN-gamma in the pathology of experimental endotoxemia. J. Immunol. 145, 2920-2924 (1990).
19. Bone, R.C. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine. Chest 101, 1644-1655 (1992).
20. Kaul, M., Eiselstein, J., Kempeni, J. & Daum, L. TNF-neutralization in sepsis guided by IL-6 serum levels. Sixth International TNF Congress, Rhodes, Hellas, Greece, 8-12 May 1996. [Abstr.] Eur. Cytokine Netw, 7, 283 (1996).